Ramesh Kumar - 18 Apr 2022 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
Director
Signature
Ramesh Kumar by Shankar Musunuri, his attorney-in-fact
Issuer symbol
OCGN
Transactions as of
18 Apr 2022
Net transactions value
-$17,400
Form type
4
Filing time
20 Apr 2022, 16:03:01 UTC
Previous filing
20 Jan 2022
Next filing
08 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCGN Common Stock Options Exercise $3,825 +7,500 $0.5100 7,500 18 Apr 2022 Direct
transaction OCGN Common Stock Sale $21,225 -7,500 -100% $2.83* 0 18 Apr 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCGN Option (Right to Buy) Options Exercise $0 +7,500 +83% $0.000000 16,500 18 Apr 2022 Common Stock 7,500 $0.5100 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.79 to $2.89. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The options, initially representing a right to purchase 54,000 shares, vest and become exercisable in equal monthly installments over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates.